Related Experiment Videos
[Patched/Sonic Hedgehog pathway and basal cell carcinoma]
Nicole Basset-Seguin1, Nadem Soufir
1Inserm U.532, Institut de recherche sur la peau, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. nbs@chu-stlouis.fr
Medecine Sciences : M/S
|October 6, 2004
Summary
The Sonic Hedgehog pathway is key in developing basal cell carcinoma (BCC) and Gorlin syndrome. New mouse models aid research into these disabling skin tumors and potential treatments.
Area of Science:
- Oncology
- Developmental Biology
- Genetics
Background:
- Basal cell carcinoma (BCC) and Gorlin syndrome share developmental pathways.
- The Patched Sonic Hedgehog (SHH) pathway is implicated in BCC and Gorlin syndrome pathogenesis.
- Understanding these mechanisms is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the molecular mechanisms of BCC and Gorlin syndrome development.
- To introduce novel murine models for studying these conditions.
- To identify potential therapeutic strategies for disabling forms of BCC.
Main Methods:
- Utilized newly developed murine models.
- Investigated molecular events in tumor development.
- Focused on the Patched Sonic Hedgehog pathway.
Main Results:
- Established in vivo models for BCC and Gorlin syndrome research.
- Advanced understanding of SHH pathway's role in tumorigenesis.
- Provided a platform for preclinical therapeutic screening.
Conclusions:
- Murine models offer valuable insights into BCC and Gorlin syndrome.
- The SHH pathway is a critical target for therapeutic intervention.
- Further research in these models can lead to effective treatments for disabling BCC forms.